Kroenke M[au] - Search Results

Year	Number of Results
2005	1
2007	1
2008	2
2009	1
2010	3
2011	1
2012	2
2013	2
2014	1
2015	1
2017	8
2018	1
2019	4
2020	6
2021	4
2022	5
2023	2
2024	1

1

Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology.

Zhou Y, Penny HL, Kroenke MA, Bautista B, Hainline K, Chea LS, Parnes J, Mytych DT. Zhou Y, et al. Among authors: kroenke ma. J Immunother Cancer. 2022 Apr;10(4):e004225. doi: 10.1136/jitc-2021-004225. J Immunother Cancer. 2022. PMID: 35444060 Free PMC article. Review.

2

Immunogenicity Risk Assessment for Multi-specific Therapeutics.

Kroenke MA, Milton MN, Kumar S, Bame E, White JT. Kroenke MA, et al. AAPS J. 2021 Nov 5;23(6):115. doi: 10.1208/s12248-021-00642-5. AAPS J. 2021. PMID: 34741215 Free PMC article. Review.

3

Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays.

Ducret A, Ackaert C, Bessa J, Bunce C, Hickling T, Jawa V, Kroenke MA, Lamberth K, Manin A, Penny HL, Smith N, Terszowski G, Tourdot S, Spindeldreher S. Ducret A, et al. Among authors: kroenke ma. MAbs. 2022 Jan-Dec;14(1):1993522. doi: 10.1080/19420862.2021.1993522. MAbs. 2022. PMID: 34923896 Free PMC article. Review.

4

Development and optimization of neutralizing antibody assays to monitor clinical immunogenicity.

Civoli F, Kroenke MA, Reynhardt K, Zhuang Y, Kaliyaperumal A, Gupta S. Civoli F, et al. Among authors: kroenke ma. Bioanalysis. 2012 Nov;4(22):2725-35. doi: 10.4155/bio.12.239. Bioanalysis. 2012. PMID: 23210655 Review.

5

Measuring and distilling the impact of pain.

Kroenke MD. Kroenke MD. Pain. 2009 Mar;142(1-2):7-8. doi: 10.1016/j.pain.2009.01.012. Epub 2009 Feb 6. Pain. 2009. PMID: 19201095 No abstract available.

6

A Proposal to Redefine Clinical Immunogenicity Assessment.

Mytych DT, Hock MB, Kroenke M, Jawa V, Kaliyaperumal A, Zhou Y. Mytych DT, et al. Among authors: kroenke m. AAPS J. 2017 May;19(3):599-602. doi: 10.1208/s12248-017-0059-7. Epub 2017 Feb 28. AAPS J. 2017. PMID: 28247192

7

Delayed Imaging Improves Lesion Detectability in [^99mTc]Tc-PSMA-I&S SPECT/CT in Recurrent Prostate Cancer.

Berliner C, Steinhelfer L, Chantadisai M, Kroenke M, Koehler D, Pose R, Bannas P, Knipper S, Eiber M, Maurer T. Berliner C, et al. Among authors: kroenke m. J Nucl Med. 2023 Jul;64(7):1036-1042. doi: 10.2967/jnumed.122.265252. Epub 2023 May 25. J Nucl Med. 2023. PMID: 37230531

8

EAE mediated by a non-IFN-γ/non-IL-17 pathway.

Kroenke MA, Chensue SW, Segal BM. Kroenke MA, et al. Eur J Immunol. 2010 Aug;40(8):2340-8. doi: 10.1002/eji.201040489. Eur J Immunol. 2010. PMID: 20540117 Free PMC article.

9

Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target.

Kroenke MA, Barger TE, Hu J, Miller MJ, Kalenian K, He L, Hsu H, Bartley Y, Chow VF, Teixeira Dos Santos MC, Sullivan BA, Cheng LE, Parnes JR, Padaki R, Kuhns S, Mytych DT. Kroenke MA, et al. Front Immunol. 2021 Dec 14;12:782788. doi: 10.3389/fimmu.2021.782788. eCollection 2021. Front Immunol. 2021. PMID: 34970265 Free PMC article.

10

BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms.

Hatzi K, Nance JP, Kroenke MA, Bothwell M, Haddad EK, Melnick A, Crotty S. Hatzi K, et al. Among authors: kroenke ma. J Exp Med. 2015 Apr 6;212(4):539-53. doi: 10.1084/jem.20141380. Epub 2015 Mar 30. J Exp Med. 2015. PMID: 25824819 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

37 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year